Literature DB >> 15319443

Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein.

Jui-Ling Chou1, Chuen-Lin Huang, Hsing-Lin Lai, Amos C Hung, Chen-Li Chien, Yu-Ya Kao, Yijuang Chern.   

Abstract

In the present study, we used the N terminus (amino acids 1 approximately 160) of type VI adenylyl cyclase (ACVI) as bait to screen a mouse brain cDNA library and identified Snapin as a novel ACVI-interacting molecule. Snapin is a binding protein of SNAP25, a component of the SNARE complex. Co-immunoprecipitation analyses confirmed the interaction between Snapin and full-length ACVI. Mutational analysis revealed that the interaction domains of ACVI and Snapin were located within amino acids 1 approximately 86 of ACVI and 33-51 of Snapin, respectively. Co-localization of ACVI and Snapin was observed in primary hippocampal neurons. Moreover, expression of Snapin specifically eliminated protein kinase C (PKC)-mediated suppression of ACVI, but not that of cAMP-dependent protein kinase (PKA) or calcium. Mutation of the potential PKC and PKA phosphorylation sites of Snapin did not affect the ability of Snapin to reverse the PKC inhibitory effect on ACVI. Phosphorylation of Snapin by PKC or PKA therefore might not be crucial for Snapin action on ACVI. In contrast, Snapin(Delta33-51), which harbors an internal deletion of amino acids 33-51 did not affect PKC-mediated inhibition of ACVI, supporting that amino acids 33-51 of Snapin comprises the ACVI-interacting region. Consistently, Snapin exerted no effect on PKC-mediated inhibition of an ACVI mutant (ACVI-DeltaA87), which lacked the Snapin-interacting region (amino acids 1-86). Snapin thus reverses its action via direct interaction with the N terminus of ACVI. Collectively, we demonstrate herein that in addition to its association with the SNARE complex, Snapin also functions as a regulator of an important cAMP synthesis enzyme in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319443     DOI: 10.1074/jbc.M407206200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Adenylyl cyclase AC8 directly controls its micro-environment by recruiting the actin cytoskeleton in a cholesterol-rich milieu.

Authors:  Laura J Ayling; Stephen J Briddon; Michelle L Halls; Gerald R V Hammond; Luis Vaca; Jonathan Pacheco; Stephen J Hill; Dermot M F Cooper
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

Review 2.  Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity.

Authors:  A G Miriam Leenders; Zu-Hang Sheng
Journal:  Pharmacol Ther       Date:  2005-01       Impact factor: 12.310

3.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

4.  Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor.

Authors:  Shyi-Chyi Wang; Hsing-Lin Lai; Yi-Ting Chiu; Ren Ou; Chuen-Lin Huang; Yijuang Chern
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

5.  N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.

Authors:  Rachna Sadana; Nathan Dascal; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-09-25       Impact factor: 4.436

6.  Type VI adenylyl cyclase regulates neurite extension by binding to Snapin and Snap25.

Authors:  Chia-Shan Wu; Jiun-Tsai Lin; Chen-Li Chien; Wei-Cheng Chang; Hsing-Lin Lai; Ching-Pang Chang; Yijuang Chern
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

Review 7.  Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Authors:  Mei Hua Gao; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2011-02-23       Impact factor: 5.000

8.  Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells.

Authors:  Sebastian Wachten; Nanako Masada; Laura-Jo Ayling; Antonio Ciruela; Viacheslav O Nikolaev; Martin J Lohse; Dermot M F Cooper
Journal:  J Cell Sci       Date:  2010-01-01       Impact factor: 5.285

9.  A novel noncanonical signaling pathway for the μ-opioid receptor.

Authors:  Lei Zhang; Horace H Loh; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2013-09-23       Impact factor: 4.436

Review 10.  Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.

Authors:  Rachna Sadana; Carmen W Dessauer
Journal:  Neurosignals       Date:  2008-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.